Search research articles
Contact Us
Filters
Showing results (11-20 of 38) with videos related to
Page
of 4
Sort By:
Kaku Igaku. the Japanese Journal of Nuclear Medicine
|
February 4, 2026
[The 47th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 50th Survey in 2024)]
, Hidehiko Okazawa, Tomoya Uehara, et al.
Annals of Nuclear Medicine
|
April 17, 2020
Radiation exposure in nurses during care of <sup>131</sup>I-MIBG therapy for pediatric patients with high-risk neuroblastoma
Yuka Taniguchi, Hiroshi Wakabayashi, Anri Inaki, et al.
Asia Oceania Journal of Nuclear Medicine & Biology
|
July 14, 2016
Extremity Radioactive Iodine Uptake on Post-therapeutic Whole Body Scan in Patients with Differentiated Thyroid Cancer
Hiroshi Wakabayashi, Junichi Taki, Anri Inaki, et al.
Annals of Nuclear Medicine
|
July 5, 2011
Double-phase (131)I whole body scan and (131)I SPECT-CT images in patients with differentiated thyroid cancer: their effectiveness for accurate identification
Hiroshi Wakabayashi, Kenichi Nakajima, Makoto Fukuoka, et al.
Asia Oceania Journal of Nuclear Medicine & Biology
|
July 14, 2016
Thyroid hormone replacement one day before (131)I therapy in patients with well-differentiated thyroid cancer
Daiki Kayano, Junichi Taki, Anri Inaki, et al.
Scientific Reports
|
February 21, 2024
Radiation exposure lymphocyte damage assessed by γ-H2AX level using flow cytometry
Zhuoqing Chen, Hiroshi Wakabayashi, Rie Kuroda, et al.
Nuclear Medicine Communications
|
August 31, 2011
Low-dose (123)I-metaiodobenzylguanidine diagnostic scan is inferior to (131)I-metaiodobenzylguanidine posttreatment scan in detection of malignant pheochromocytoma and paraganglioma
Daiki Kayano, Junichi Taki, Makoto Fukuoka, et al.
Annals of Nuclear Medicine
|
July 19, 2013
Prognostic values of initial responses to low-dose (131)I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
Hiroshi Wakabayashi, Junichi Taki, Anri Inaki, et al.
Annals of Nuclear Medicine
|
December 25, 2012
Sensitive immunodetection of radiotoxicity after iodine-131 therapy for thyroid cancer using γ-H2AX foci of DNA damage in lymphocytes
Mariko Doai, Naoto Watanabe, Tomoko Takahashi, et al.
Annals of Nuclear Medicine
|
December 16, 2014
Optimization of attenuation and scatter corrections in sentinel lymph node scintigraphy using SPECT/CT systems
Hiroto Yoneyama, Hiroyuki Tsushima, Masahisa Onoguchi, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 38) with videos related to
Sort By:
Page
of 4
Kaku Igaku. the Japanese Journal of Nuclear Medicine
|
February 4, 2026
[The 47th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 50th Survey in 2024)]
, Hidehiko Okazawa, Tomoya Uehara, et al.
Annals of Nuclear Medicine
|
April 17, 2020
Radiation exposure in nurses during care of <sup>131</sup>I-MIBG therapy for pediatric patients with high-risk neuroblastoma
Yuka Taniguchi, Hiroshi Wakabayashi, Anri Inaki, et al.
Asia Oceania Journal of Nuclear Medicine & Biology
|
July 14, 2016
Extremity Radioactive Iodine Uptake on Post-therapeutic Whole Body Scan in Patients with Differentiated Thyroid Cancer
Hiroshi Wakabayashi, Junichi Taki, Anri Inaki, et al.
Annals of Nuclear Medicine
|
July 5, 2011
Double-phase (131)I whole body scan and (131)I SPECT-CT images in patients with differentiated thyroid cancer: their effectiveness for accurate identification
Hiroshi Wakabayashi, Kenichi Nakajima, Makoto Fukuoka, et al.
Asia Oceania Journal of Nuclear Medicine & Biology
|
July 14, 2016
Thyroid hormone replacement one day before (131)I therapy in patients with well-differentiated thyroid cancer
Daiki Kayano, Junichi Taki, Anri Inaki, et al.
Scientific Reports
|
February 21, 2024
Radiation exposure lymphocyte damage assessed by γ-H2AX level using flow cytometry
Zhuoqing Chen, Hiroshi Wakabayashi, Rie Kuroda, et al.
Nuclear Medicine Communications
|
August 31, 2011
Low-dose (123)I-metaiodobenzylguanidine diagnostic scan is inferior to (131)I-metaiodobenzylguanidine posttreatment scan in detection of malignant pheochromocytoma and paraganglioma
Daiki Kayano, Junichi Taki, Makoto Fukuoka, et al.
Annals of Nuclear Medicine
|
July 19, 2013
Prognostic values of initial responses to low-dose (131)I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
Hiroshi Wakabayashi, Junichi Taki, Anri Inaki, et al.
Annals of Nuclear Medicine
|
December 25, 2012
Sensitive immunodetection of radiotoxicity after iodine-131 therapy for thyroid cancer using γ-H2AX foci of DNA damage in lymphocytes
Mariko Doai, Naoto Watanabe, Tomoko Takahashi, et al.
Annals of Nuclear Medicine
|
December 16, 2014
Optimization of attenuation and scatter corrections in sentinel lymph node scintigraphy using SPECT/CT systems
Hiroto Yoneyama, Hiroyuki Tsushima, Masahisa Onoguchi, et al.
Page
of 4